| アブストラクト | BACKGROUND: Although acute respiratory infections can lead to cardiovascular complications, the effect of underlying cardiovascular risk on the incidence of acute respiratory infections and cardiovascular complications following acute respiratory infection in individuals without established cardiovascular disease is unknown. We aimed to investigate whether cardiovascular risk is associated with increased risk of acute respiratory infection and acute cardiovascular events after acute respiratory infection using 10 years of linked electronic health record (EHR) data in England. METHODS: In this retrospective, population-based cohort study we used EHRs from primary care providers registered on the Clinical Practice Research Datalink (CPRD) GOLD and Aurum databases in England. Eligible individuals were aged 40-64 years, did not have established cardiovascular disease or a chronic health condition that would make them eligible for influenza vaccination, were registered at a general practice contributing to the CPRD, and had linked Hospital Episode Statistics Admitted Patient Care data in England from Sept 1, 2008, to Aug 31, 2018. We classified cardiovascular risk on the basis of diagnosed hypertension and overall predicted cardiovascular risk, estimated by use of the QRISK2 risk-prediction tool (comparing a score of >/=10% [increased risk] with a score of <10% [low risk]). Using multivariable Poisson regression models, we calculated incidence rate ratios (IRRs) for systemic acute respiratory infection. Among individuals who had an acute respiratory infection, we used multivariable Cox regression to calculate hazard ratios (HRs) for the risk of acute cardiovascular events within 1 year of infection. FINDINGS: We identified 6 075 321 individuals aged 40-64 years with data in the CPRD and linked data in the Hospital Episode Statistics Admitted Patient Care database between Sept 1, 2008, and Aug 31, 2018. Of these individuals, 4 212 930 (including 526 480 [12.5%] with hypertension and 607 087 [14.4%] with a QRISK2 score of >/=10%) were included in the assessment of the incidence of acute respiratory infection. After adjusting for confounders (age, sex, ethnicity, socioeconomic status, body-mass index, alcohol consumption, smoking status, and consultation frequency in the hypertension analysis; and alcohol consumption and consultation frequency in the QRISK2 analysis), the incidence of acute respiratory infection was higher in individuals with hypertension than those without (IRR 1.04 [95% CI 1.03-1.05]) and higher in those with a QRISK2 score of 10% or higher than in those with a QRISK2 score of less than 10% (1.39 [1.37-1.40]). Of the 442 408 individuals who had an acute respiratory infection, 4196 (0.9%) had an acute cardiovascular event within 1 year of infection. After adjustment (for age, sex, ethnicity, socioeconomic status, body-mass index, alcohol consumption, and smoking status in the hypertension analysis; and for alcohol consumption in the QRISK2 analysis), hypertension (HR 1.98 [95% CI 1.83-2.15]) and a QRISK2 score of 10% or higher (3.65 [3.42-3.89]) were associated with a substantially increased risk of acute cardiovascular events after acute respiratory infection. INTERPRETATION: People with increased cardiovascular risk but without diagnosed cardiovascular disease, measured by diagnosed hypertension or overall predicted cardiovascular risk, could benefit from influenza and pneumococcal vaccine prioritisation to reduce their risk of both acute respiratory infection and cardiovascular complications following an acute respiratory infection. FUNDING: British Heart Foundation and the Wellcome Trust. |
|---|
| ジャーナル名 | The Lancet. Digital health |
|---|
| Pubmed追加日 | 2021/11/27 |
|---|
| 投稿者 | Davidson, Jennifer A; Banerjee, Amitava; Smeeth, Liam; McDonald, Helen I; Grint, Daniel; Herrett, Emily; Forbes, Harriet; Pebody, Richard; Warren-Gash, Charlotte |
|---|
| 組織名 | Department of Non-Communicable Disease Epidemiology, London School of Hygiene &;Tropical Medicine, London, UK. Electronic address: jennifer.davidson@lshtm.ac.uk.;Institute of Health Informatics, University College London, London, UK.;Tropical Medicine, London, UK; National Institute for Health Research Health;Protection Research Unit in Immunisation, London School of Hygiene & Tropical;Medicine, London, UK.;Department of Infectious Disease Epidemiology, London School of Hygiene &;Tropical Medicine, London, UK.;Tropical Medicine, London, UK; Population Health Sciences, Bristol Medical;School, University of Bristol, Bristol, UK.;National Infection Service, Public Health England, London, UK. |
|---|
| Pubmed リンク | https://www.ncbi.nlm.nih.gov/pubmed/34823706/ |
|---|
